| 000 | 01073 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513121658.0 | ||
| 264 | 0 | _c19970806 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0085-5928 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Hogezand, R A | |
| 245 | 0 | 0 |
_aNew therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. _h[electronic resource] |
| 260 |
_bScandinavian journal of gastroenterology. Supplement _c1997 |
||
| 300 |
_a105-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-10 _xtherapeutic use |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
| 700 | 1 | _aVerspaget, H W | |
| 773 | 0 |
_tScandinavian journal of gastroenterology. Supplement _gvol. 223 _gp. 105-7 |
|
| 999 |
_c9180830 _d9180830 |
||